Startseite>>3-Aminophenylboronic Acid Monohydrate (contains varying amounts of Anhydride)

3-Aminophenylboronic Acid Monohydrate (contains varying amounts of Anhydride)

Katalog-Nr.GD00220

Products are for research use only. Not for human use. We do not sell to patients.

3-Aminophenylboronic Acid Monohydrate (contains varying amounts of Anhydride) Chemische Struktur

Cas No.: 206658-89-1

Größe Preis Lagerbestand Menge
5g
24,00 $
Auf Lager
25g
80,00 $
Auf Lager
100g
157,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
3-Aminophenylboronic acid monohydrate is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

It is employed as a reagent in the preparation of Suzuki-Miyaura cross-coupling, used for Gram-positive ant virulence drugs and inhibitors of Streptococcus agalactiae Stk1, regioisomer of Zaleplon (a sedative), amphiphilic random glycopolymer, which self-assemble to form NANOPARTICLES, with Potential as a Glucose-Sensitive Matrix, ChemomeChanical Polymer that Expands and Contracts in Blood Plasma with High Glucose SELECTIVI Ty. Aminophenylboronic Acid is Also used as a reagent in the preparation of nonbenzodiazepine hypnotic agents.

Bewertungen

Review for 3-Aminophenylboronic Acid Monohydrate (contains varying amounts of Anhydride)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 3-Aminophenylboronic Acid Monohydrate (contains varying amounts of Anhydride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.